Freenome Tech Stack

Blood-based cancer detection platform using multiomics and machine learning

Biotechnology Research Brisbane, California 201–500 employees Founded 2014 Privately Held

Freenome develops blood tests for early-stage cancer detection using multiomics data and computational biology. The tech stack reveals a hybrid biotech-software operation: laboratory infrastructure (Illumina, LIMS, Veeva Vault) sits alongside cloud platforms (GCP, AWS, Azure) and ML tooling (Airflow, Flyte, Python). Current hiring skews research-heavy (8 roles) with meaningful engineering investment (5 roles), while active projects span distributed deep-learning pipelines and NGS workflow optimization—signaling the company is scaling computational infrastructure to handle genomic data at volume.

Tech Stack 37 technologies

Core StackPalo Alto Networks Prisma Kubernetes Java Python Docker MySQL Salesforce HubSpot ZoomInfo Tableau Power BI Looker Greenhouse AWS Jira Apache Airflow SAP NetSuite Pulumi GCP VMware vSphere Juniper Networks Panorama Veeva Vault Azure Paylocity LIMS Flyte Illumina+6 more

AdoptingAWS EMR

What Freenome Is Building

◆Challenges

Adoption of screening in health systems
Adoption of blood-based cancer screening solutions
Speed and efficiency of fp&a
Clinical adoption
Massive-scale genomic data challenges
Distributed dl pipeline optimization
Hardware utilization optimization
Optimizing ngs workflows
Scaling complex assays
Troubleshooting workflow issues

▲Active Projects

Implement emr and ux tools
It infrastructure change implementation
Financial systems implementation
Early blood-based detection tests for cancer
Drive software testing lifecycle strategy
Model optimization
Distributed dl pipeline infrastructure
Research experiments in computational biology
Ngs method development
Assay scale-up and transfer

Hiring Activity

Accelerating30 roles · 10 in 30d

Department

Research

Engineering

Finance

Sales

Marketing

Product

Ops

Seniority

Senior

Director

Mid

Manager

Staff

Notable leadership hires: Finance Director

Company intelligence

Find more companies like Freenome by tech stack, pain points and active projects

Get started free

About Freenome

Freenome is a biotech company founded in 2014 focused on blood-based cancer screening. The company has developed a multiomics platform designed to detect early-stage colorectal cancer and advanced adenomas through machine learning analysis of cell-free DNA and other blood biomarkers. The organization operates across three main areas: wet-lab research and assay development; computational biology and ML model training; and clinical adoption and commercialization. Freenome is based in Brisbane, California, and has raised over $1.1 billion from investors including Roche, Novartis, and Kaiser Permanente, among others.

HeadquartersBrisbane, California

Company Size201–500 employees

Founded2014

Hiring MarketsUnited States

Frequently Asked Questions

What is Freenome's cancer detection platform based on?

Freenome uses a multiomics platform that analyzes blood samples to detect early-stage colorectal cancer and advanced adenomas. The approach combines cell-free DNA analysis with machine learning and computational biology techniques.

What tech stack does Freenome use?

Freenome's stack spans cloud (GCP, AWS, Azure), containerization (Kubernetes, Docker), data processing (Apache Airflow, Flyte), databases (MySQL), lab informatics (Veeva Vault, LIMS, Illumina), and analytics (Tableau, Power BI, Looker). The company is currently adopting AWS EMR.

How this profile is built

Freenome's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.